UCB

UCB
Real-time Euronext Bruxelles - 11:36 2022-12-02 am EST
74.04 EUR +3.21%

Turn to zoom
Prev.74.04000000
Open71.70000000
High74.10000000
Low71.68000000
Volume303 051
Latest news
1d ago
1d ago
1d ago
11/24
Chart UCB
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBearish
Resistance75,286,688,3
Spread/Res.-1,5%-14%-16%
Spread/Supp.3,2%11%7,5%
Support71,767,068,9
Financials
Sales 2022 5 351 M 5 617 M 5 617 M
Net income 2022 541 M 568 M 568 M
Net Debt 2022 2 441 M 2 562 M 2 562 M
P/E ratio 2022 27,1x
Yield 2022 1,82%
Capitalization 14 065 M 14 763 M 14 763 M
EV / Sales 2022 3,08x
EV / Sales 2023 3,02x
Nbr of Employees 8 600
Free-Float 59,6%
Company
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector :
Biopharmaceuticals
Calendar :
2022-12-05 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Last Close Price 74,04 €
Average target price 99,57 €
Spread / Average Target 34,5%